The genomic model was trained on the Cerebras Wafer Scale Cluster in the Cerebras cloud. The results were achieved by combining publicly available human reference genome data with Mayo's comprehensive patient exome data.

1 Billion
Parameters

10x larger than AlphaFold

1 Trillion
Tokens

Leveraging Mayo’s
in-house patient data

Highest Accuracy for Clinical Evals

Outperforms today's best models

Combining AI and domain expertise
to produce better patient outcomes

"Mayo is committed to fundamentally transforming healthcare by using the most advanced AI technology. We’ve been able to develop AI tools with such promise in less than a year, in part, because of our collaboration with Cerebras that enabled us to create this state-of-the-art AI model for genomics."

Matthew Callstrom, MD, PhD

Medical Director for Strategy, Chair - Dept. of Radiology

“It is an honor to collaborate with Mayo Clinic, the top-ranked hospital in the nation. With its recognized leadership in delivering medical outcomes, we are uniquely positioned to combine AI and medicine. The state-of-the-art AI models we are developing together will work alongside doctors to help with patient diagnosis, treatment planning, and outcome estimation.”

Andrew Feldman

CEO and co-founder, Cerebras

This new state-of-the-art foundation model for genomics achieves unprecedented accuracy in disease prediction

Cancer Predisposing

Cardiovascular Predisposing

Drug Response for Rheumatoid Arthritis

Unlock the power of AI for your organization

Cerebras And Mayo Clinic Announce Foundation Model For Healthcare

READ MORE

Cerebras Systems teams with Mayo Clinic on genomic model that predicts arthritis treatment

READ MORE

Cerebras Systems and Mayo Clinic Unveil Best in Class Genomic Foundation Model

READ MORE

Cerebras Systems and Mayo Clinic Unveil Best in Class Genomic Foundation Model

READ MORE

Working together to pioneer new LLMs to improve patient outcomes and diagnoses using Mayo Clinic’s robust longitudinal data repository and Cerebras’ industry-leading generative AI compute to accelerate breakthrough insights